Clinical trial
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate Alone for Tocolysis in Pregnant Women at 28 - 31 Weeks Gestation With Threatened Preterm Labor
NCT05345132 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate Alone for Tocolysis in Pregnant Women at 28 - 31 Weeks Gestation With Threatened Preterm Labor
- Lead sponsor
- Assiut University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 10, 2022
- Completion date
- February 1, 2026
- Enrollment
- 264 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
threatened preterm labor